Sleep duration, snoring habits, and cardiovascular disease risk factors in an ethnically diverse population

Journal of Cardiovascular Nursing

Volumn 27, Issue 3, 2012, Pages 263-269

  Mosca, Matthew ^a   Aggarwal, Brooke ^b  

^a FRANKLIN AND MARSHALL COLLEGE   (United States)

^b NewYork Presbyterian Hospital   (United States)

Author keywords

cardiovascular disease; psychosocial; risk factors; sleep; snoring

Indexed keywords

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CROSS-SECTIONAL STUDY; FEMALE; HUMAN; MALE; MIDDLE AGED; RISK FACTOR; SLEEP; SNORING; TIME;

ADULT; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; SLEEP; SNORING; TIME FACTORS;

EID: 84859998099     PISSN: 08894655     EISSN: 15505049     Source Type: Journal    
DOI: 10.1097/JCN.0b013e31821e7ad1     Document Type: Article

References (32)

1. Sabanayagam C, Shanka A. Sleep duration and cardiovascular disease: results from the National Health Survey. Sleep. 2010; 33: 1037-1042.
2. Ikehara S, Iso H, Date C, et al. Association of sleep duration with mortality from cardiovascular disease and other causes for Japanese men and women: the JACC study. Sleep. 2009; 32: 295-301.
3. Amagai Y, Ishikawa S, Gotoh T, Kayaba K, Nakamura Y, Kajii E. Sleep duration and incidence of cardiovascular events in a Japanese population: the Jichi Medical School cohort study. J Epidemiol. 2010; 20: 106-110.
4. Ayas NT, White DP, Manson JE, et al. A prospective study of sleep duration and coronary heart disease in women. Arch Inter Med. 2003; 163: 205-209. (Pubitemid 36120188)
5. Qureshi Al, GilesWH, Croft JB, Bliwise DL. Habitual sleep patterns and risk for stroke and coronary heart disease: a 10-year follow-up from NHANES I. Neurology. 1997; 48: 904-911.
6. Spiegel K, Knutson K, Leproult R, Tasali E, Van Cauter E. Sleep loss: a novel risk factor for insulin resistance and type 2 diabetes. J Appl Physiol. 2005; 99 (5): 2008-2019. (Pubitemid 41547204)
7. Cappuccio FP, D'Elia L, Strazzullo P, MillerMA. Quantity and quality of sleep and incidence of type 2 diabetes: a systematic review and meta-analysis. Diabetes Care. 2010; 33: 414-420.
8. Gangwisch JE, Heymsfield SB, Boden-Albala B, et al. Short sleep duration as a risk factor for hypertension: analyses of the first National Health and Nutrition Examination Survey. Hypertension. 2006; 47: 833-839. (Pubitemid 44297552)
9. Cappuccio FP, D'Elia L, Strazzullo P, MillerMA. Sleep duration and all-cause mortality: a systematic review and metaanalysis of prospective studies. Sleep. 2010; 33: 585-592.
10. Gallicchio L, Kalesan B. Sleep duration and mortality: a systematic review and meta-analysis. J Sleep Res. 2009; 18: 148-158.
11. Ferrie JE, Shipley MJ, Cappuccio FP, et al. A prospective study of change in sleep duration: associations with mortality in the Whitehall II cohort. Sleep. 2007; 30: 1659-1666. (Pubitemid 350234744)
12. Patel SR, Ayas NT,MalhotraMR, et al. A prospective study of sleep duration and mortality risk in women. Sleep. 2004; 27: 440-444. (Pubitemid 44138804)
13. Eguchi K, Pickering TG, Schwartz JE, et al. Short sleep duration as an independent predictor of cardiovascular events in Japanese patients with hypertension. Arch Intern Med. 2008; 168: 2225-2231.
14. Knutson KL, Cauter EV, Rathouz JP, DeLeire TD, Lauderdale DS. Trends in the prevalence of short sleepers in the USA: 1975-2006. Sleep. 2010; 33: 37-45.
15. Knutson KL, Spiegel K, Penev P, Van Cauter E. The metabolic consequences of sleep deprivation. Sleep. 2007; 11: 163-178. (Pubitemid 46778995)
16. Gangwisch JE. Epidemiological evidence for the links between sleep, circadian rhythms and metabolism. Obes Rev. 2009; 10: 37-45.
17. Donga E, Van Dijk M, Van Dijk G, et al. A single night of partial sleep deprivation induces insulin resistance in multiple metabolic pathways in healthy subjects. J Clin Endocrinol Metab. 2010; 10: 1-6.
18. Taheri S, Lin L, Austin D, Young T, Mignot E. Short sleep duration is associated with reduced leptin, elevated ghrelin, and increased body mass index. PLoS Med. 2004; 1: e62.
19. Gangwisch JE, Malaspina D, Babiss LA, et al. Short sleep duration as a risk factor for hypercholesterolemia: analysis of the National Longitudinal Study of Adolescent Health. Sleep. 2010; 33: 956-961.
20. Williams CJ,Hu FB, Patel SR, Mantzoros CS. Sleep duration and snoring in relation to biomarkers of cardiovascular disease risk among women with type 2 diabetes. Diabetes Care. 2007; 30: 1233-1240. (Pubitemid 46684653)
21. Kaneita Y, Uchiyama M, Yoshike N, Ohida T. Associations of usual sleep duration with serum lipid and lipoprotein levels. Sleep. 2008; 31: 645-652. (Pubitemid 351694253)
22. National Institutes of Health. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adultsVthe evidence report. Obes Res. 1998; 6 (suppl 2): 51S-209S.
23. Parikh P, Mochari H, Mosca L. Clinical utility of a fingerstick technology to identify individuals with abnormal lipids and high sensitivity C-reactive protein (hsCRP) levels. Am J Health Promot. 2009; 23 (4): 279-282.
24. Mosca L, Banka CL, Benjamin EJ, et al. 2007 update: American Heart Association evidence-based guidelines for cardiovascular disease prevention in women. Circulation. 2007; 115 (11): 1481-1501. (Pubitemid 46648385)
25. Grundy SM, Cleeman JI, Merz CN, et al. National Heart, Lung, and Blood Institute; American College of Cardiology Foundation; American Heart Association. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation. 2004; 110: 227-239. (Pubitemid 38924592)
26. Grundy S, Brewer B, James C, et al. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association Conference on scientific issues related to the definition. Circulation. 2004; 109: 433-438. (Pubitemid 38133916)
27. Rosengren A, Hawken S, Ounpuu S, et al; INTERHEART Investigators. Association of psychosocial risk factors with risk of acute myocardial infarction in 11119 cases and 13648 controls from 52 countries (the INTERHEART study): casecontrol study. Lancet. 2004; 364 (9438): 953-962. (Pubitemid 39208456)
28. Marshall NS, Glozier N, Grunstein RR. Is sleep duration related to obesity? A critical review of the epidemiological evidence. Sleep Med Rev. 2008; 12: 289-298.
29. Meek D, Chakravorty I. Obstructive sleep apnea increases risk of CVD. Practitioner. 2009; 253: 17-20.
30. Cappuccio FP, Stranges S, Kandala NB, et al. Genderspecific associations of short sleep duration with prevalent and incident hypertension: the Whitehall II study. Hypertension. 2007; 50: 693-700. (Pubitemid 47442733)
31. Signal TL, Gale J, Gander PH, et al. Sleep measurement in flight crew: comparing actigraphic and subjective estimates to polysomnography. Aviat Space Environ Med. 2005; 76: 1058-1063. (Pubitemid 41619130)
32. Gordon DJ, Probstfield JL, Garrison RJ, et al. High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. Circulation. 1989; 79: 8-15. (Pubitemid 19043669)